Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Maschmeyer

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
International Journal of Antimicrobial Agents|May 19, 2006
The changing epidemiology of invasive fungal infections: new threatsGeorg Maschmeyer
Current Infectious Disease Reports|September 30, 2011
Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic cancer patientsGeorg Maschmeyer
The Journal of Antimicrobial Chemotherapy|April 18, 2009
The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Prevention of mould infectionsGeorg Maschmeyer
International Journal of Antimicrobial Agents|August 21, 2007
The epidemiology and treatment of infections in cancer patientsGeorg Maschmeyer, Antje Haas
Mycoses|June 29, 2005
Pharmacological properties and clinical efficacy of a recently licensed systemic antifungal, caspofunginGeorg Maschmeyer, Axel Glasmacher
Medical Mycology|November 10, 2018
Defining clinical failure for salvage studiesGeorg Maschmeyer, Antje Haas
Future Microbiology|July 31, 2007
Voriconazole: a broad spectrum triazole for the treatment of serious and invasive fungal infectionsGeorg Maschmeyer, Antje Haas
Annals of Hematology|March 15, 2006
Update on management of infections in cancer and stem cell transplant patientsStefan Neuburger, Georg Maschmeyer
Mycoses|June 26, 2014
Our 2014 approach to breakthrough invasive fungal infectionsGeorg Maschmeyer, Thomas F Patterson
British Journal of Haematology|January 6, 2016
How to manage lung infiltrates in adults suffering from haematological malignancies outside allogeneic haematopoietic stem cell transplantationGeorg Maschmeyer, J Peter Donnelly
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
International Journal of Antimicrobial Agents|May 19, 2006
The changing epidemiology of invasive fungal infections: new threatsGeorg Maschmeyer
Current Infectious Disease Reports|September 30, 2011
Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic cancer patientsGeorg Maschmeyer
The Journal of Antimicrobial Chemotherapy|April 18, 2009
The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Prevention of mould infectionsGeorg Maschmeyer
International Journal of Antimicrobial Agents|August 21, 2007
The epidemiology and treatment of infections in cancer patientsGeorg Maschmeyer, Antje Haas
Mycoses|June 29, 2005
Pharmacological properties and clinical efficacy of a recently licensed systemic antifungal, caspofunginGeorg Maschmeyer, Axel Glasmacher
Medical Mycology|November 10, 2018
Defining clinical failure for salvage studiesGeorg Maschmeyer, Antje Haas
Future Microbiology|July 31, 2007
Voriconazole: a broad spectrum triazole for the treatment of serious and invasive fungal infectionsGeorg Maschmeyer, Antje Haas
Annals of Hematology|March 15, 2006
Update on management of infections in cancer and stem cell transplant patientsStefan Neuburger, Georg Maschmeyer
Mycoses|June 26, 2014
Our 2014 approach to breakthrough invasive fungal infectionsGeorg Maschmeyer, Thomas F Patterson
British Journal of Haematology|January 6, 2016
How to manage lung infiltrates in adults suffering from haematological malignancies outside allogeneic haematopoietic stem cell transplantationGeorg Maschmeyer, J Peter Donnelly
Pageof 10